Ropivacaine hydrochloride Good Manufacturer supply High Quality 132112-35-7
- Molecular Formula:C17H29ClN2O2
- Molecular Weight:328.882
- Appearance/Colour:white solid
- Vapor Pressure:1.18E-10mmHg at 25°C
- Melting Point:267-269 °C
- Boiling Point:410.2 °C at 760 mmHg
- Flash Point:201.9 °C
- PSA：41.57000
- LogP:4.25500
Ropivacaine hydrochloride (132112-35-7) Usage
(–)-Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. In vivo, (–)-ropivacaine induces complete impairment of proprioception, motor function, and nociception in the hindleg of rats when 100 μL of an 8 mM solution is injected percutaneously into the sciatic nerve. (–)-Ropivacaine depresses myocardial contractile force in isolated rat hearts less potently than (±)-ropivacaine, as well as (–)- and (±)-bupivacaine . Formulations containing (–)-ropivacaine have been used as local anesthetics during surgery and childbirth.
How to get the best price on Ropivacaine hydrochloride?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Ropivacaine hydrochloride . You can buy high quality, low price Ropivacaine hydrochloride 132112-35-7 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
